Leiomyosarcoma Clinical Trials in Los Angeles, CA

Leiomyosarcoma Clinical Trials in Los Angeles, CA

View the best 10 leiomyosarcoma medical studies in Los Angeles, California. Access promising new therapies by applying to a Los Angeles-based Leiomyosarcoma clinical trial.

Trials in Los Angeles, California

Here are the top 8 medical studies for leiomyosarcoma in Los Angeles, California

Image of Sarcoma Oncology Center in Los Angeles, United States.

Doxorubicin +1 More

Anti-tumor antibiotic

Recruiting1 awardPhase 2 & 3
This trial will test if a combo of two chemo drugs can prolong progression-free survival in those with metastatic leiomyosarcoma.
Image of Children's Hospital of Alabama in Birmingham, United States.

Doxorubicin +2 More

Anthracyclines

Recruiting1 awardPhase 2 & 3
This trial is testing whether a new drug called pazopanib, when combined with chemotherapy and radiation, works better for patients with a specific type of soft tissue cancer. Pazopanib helps stop cancer cells from growing, while chemotherapy and radiation kill the cells. The goal is to see if this combination can improve treatment outcomes.
Image of Lifespan Cancer Institute at Rhode Island Hospital in Providence, United States.

NM32-2668

Cancer Vaccine

Recruiting1 awardPhase 1
This trial is testing a new drug called NM32-2668 in adult patients with advanced solid tumors. The main goals are to check the safety and effectiveness of the drug, find the highest safe dose
Image of Children's Hospital of Orange County (Pediatrics [up to 25 years old]) in Orange, United States.

Tabelecleucel

Virus Therapy

Recruiting1 awardPhase 2
This trial tests tabelecleucel, a treatment using special immune cells, in patients with certain diseases related to the Epstein-Barr virus (EBV) who can't use or don't respond to standard treatments. It works by enhancing the immune system's ability to attack virus-infected cells. Tabelecleucel is being tested for recurring or hard-to-treat EBV-related diseases.
Image of Mayo Clinic Arizona in Phoenix, United States.

Anlotinib +1 More

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 3
This trial is currently recruiting patients with alveolar soft part sarcoma only and is no longer recruiting patients with synovial sarcoma or leiomyosarcoma.
Image of Sant P Chawla in Santa Monica, United States.

Trabectedin

Alkylating agents

Recruiting3 awardsPhase 2
This trial is testing a new combination of drugs to treat cancer. The drugs are given at lower doses than usual, and more often.
Image of Stanford Cancer Center in Stanford, United States.

Nanatinostat +2 More

HDAC inhibitor

Recruiting1 awardPhase 1 & 2
This trial tests a combination of nanatinostat, valganciclovir, and pembrolizumab in patients with certain EBV-related cancers. Nanatinostat makes cancer cells more vulnerable, allowing valganciclovir to kill them, while pembrolizumab boosts the immune system to fight the cancer.
Image of The Ottawa Hospital - General Campus in Ottawa, Canada.

Surgery

Recruiting2 awardsPhase 3
This trialtests if chemo before surgery can help people with a certain type of cancer live longer.

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.